Thus, the increased RAAS activation and the enhanced levels of Ang II, along with dyslipidemia, hyperglycemia, and insulin resistance may impose a synergistic effect on PAI-1 levels in OSA patients. This evidence concerns the gene SERPINE1 and obstructive sleep apnea syndrome.